|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 20.32 CNY | -1.74% |
|
-3.01% | -30.55% |
| 10-28 | Shanghai Baosight Software's Attributable Profit Slides 36% in Q3 | MT |
| 10-27 | Shanghai Baosight Software Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025 | CI |
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 6.89 | 6.97 | 7.37 | 7.86 | 6.95 | |||||
Return on Total Capital | 11.31 | 12.51 | 13.02 | 13.5 | 11.54 | |||||
Return On Equity % | 18.4 | 20.96 | 22.22 | 22.96 | 19.09 | |||||
Return on Common Equity | 18.13 | 21.5 | 23.06 | 24.03 | 19.96 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 28.81 | 32.56 | 32.92 | 37.09 | 34.89 | |||||
SG&A Margin | 3.95 | 4.56 | 4.49 | 5.27 | 4.75 | |||||
EBITDA Margin % | 17.41 | 18.53 | 19.29 | 22.85 | 20.37 | |||||
EBITA Margin % | 14.32 | 16.12 | 17.02 | 20.4 | 17.91 | |||||
EBIT Margin % | 14.08 | 15.89 | 16.79 | 20.2 | 17.74 | |||||
Income From Continuing Operations Margin % | 14.29 | 16.23 | 17.12 | 20.22 | 17.05 | |||||
Net Income Margin % | 13.67 | 15.47 | 16.62 | 19.77 | 16.6 | |||||
Net Avail. For Common Margin % | 13.67 | 15.47 | 16.62 | 19.77 | 16.6 | |||||
Normalized Net Income Margin | 8.68 | 9.48 | 10.54 | 12.62 | 10.86 | |||||
Levered Free Cash Flow Margin | 18.56 | 0.65 | 8.35 | 18.64 | 2.94 | |||||
Unlevered Free Cash Flow Margin | 18.57 | 0.71 | 8.44 | 18.78 | 3.09 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.78 | 0.7 | 0.7 | 0.62 | 0.63 | |||||
Fixed Assets Turnover | 5.26 | 5.44 | 5.58 | 4.85 | 4.43 | |||||
Receivables Turnover (Average Receivables) | 2.94 | 2.44 | 2.14 | 1.88 | 1.74 | |||||
Inventory Turnover (Average Inventory) | 3.67 | 2.59 | 2.84 | 2.44 | 2.84 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.67 | 1.72 | 1.83 | 1.93 | 1.98 | |||||
Quick Ratio | 1.16 | 1.27 | 1.37 | 1.47 | 1.57 | |||||
Operating Cash Flow to Current Liabilities | 0.23 | 0.24 | 0.3 | 0.29 | 0.2 | |||||
Days Sales Outstanding (Average Receivables) | 124.39 | 149.32 | 170.54 | 193.65 | 210.26 | |||||
Days Outstanding Inventory (Average Inventory) | 99.76 | 141.03 | 128.48 | 149.85 | 128.68 | |||||
Average Days Payable Outstanding | 60.94 | 89.29 | 99.96 | 118.86 | 133.12 | |||||
Cash Conversion Cycle (Average Days) | 163.21 | 201.07 | 199.06 | 224.64 | 205.82 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 0.27 | 4.47 | 4.62 | 7.57 | 7.63 | |||||
Total Debt / Total Capital | 0.27 | 4.28 | 4.42 | 7.04 | 7.09 | |||||
LT Debt/Equity | 0 | 2.17 | 2.64 | 6.13 | 6.42 | |||||
Long-Term Debt / Total Capital | 0 | 2.08 | 2.52 | 5.7 | 5.97 | |||||
Total Liabilities / Total Assets | 46.61 | 46.23 | 45.56 | 44.76 | 43.22 | |||||
EBIT / Interest Expense | 993.42 | 155.61 | 124.59 | 96.09 | 72.61 | |||||
EBITDA / Interest Expense | 1.23K | 187.24 | 147.73 | 112.24 | 86.67 | |||||
(EBITDA - Capex) / Interest Expense | 980.71 | 123.79 | 130.75 | 98.38 | 73.56 | |||||
Total Debt / EBITDA | 0.01 | 0.19 | 0.19 | 0.3 | 0.32 | |||||
Net Debt / EBITDA | -2.3 | -1.73 | -1.7 | -1.66 | -1.25 | |||||
Total Debt / (EBITDA - Capex) | 0.02 | 0.29 | 0.21 | 0.34 | 0.38 | |||||
Net Debt / (EBITDA - Capex) | -2.88 | -2.61 | -1.92 | -1.89 | -1.48 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 38.96 | 15.01 | 11.82 | -1.78 | 5.64 | |||||
Gross Profit, 1 Yr. Growth % | 34.3 | 31.13 | 13.05 | 10.67 | -0.62 | |||||
EBITDA, 1 Yr. Growth % | 50.04 | 25.54 | 16.4 | 16.36 | -5.82 | |||||
EBITA, 1 Yr. Growth % | 45.05 | 31.86 | 18.11 | 17.74 | -7.26 | |||||
EBIT, 1 Yr. Growth % | 46.08 | 32.24 | 18.14 | 18.18 | -7.22 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 47.06 | 33.67 | 17.95 | 15.99 | -10.89 | |||||
Net Income, 1 Yr. Growth % | 47.91 | 35.92 | 20.18 | 16.82 | -11.28 | |||||
Normalized Net Income, 1 Yr. Growth % | 49.55 | 31.33 | 24.22 | 17.35 | -9.05 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 46.84 | 33.49 | 20.43 | 15.28 | -11.5 | |||||
Accounts Receivable, 1 Yr. Growth % | 24.42 | 40.96 | 18.29 | 5.82 | 22.44 | |||||
Inventory, 1 Yr. Growth % | 275.53 | -0.13 | 2.79 | 11.94 | -22.72 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -9.37 | 20.2 | -0.41 | 26.56 | 7.16 | |||||
Total Assets, 1 Yr. Growth % | 37.04 | 14.29 | 9.64 | 11.75 | -1.12 | |||||
Tangible Book Value, 1 Yr. Growth % | 3.32 | 13.8 | 10.77 | 14.18 | 0.6 | |||||
Common Equity, 1 Yr. Growth % | 3.08 | 14.17 | 10.26 | 13.73 | 0.8 | |||||
Cash From Operations, 1 Yr. Growth % | 65.25 | 25.68 | 30.78 | 3.45 | -35.94 | |||||
Capital Expenditures, 1 Yr. Growth % | -63.31 | 21.27 | -60.5 | 25.04 | 16.07 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -465.21 | -93.94 | -1.26K | 143.69 | -75.7 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -467.82 | -93.34 | -1.38K | 142.69 | -74.7 | |||||
Dividend Per Share, 1 Yr. Growth % | 192.46 | 11.11 | 4.01 | 49.98 | -28 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 27.89 | 31.03 | 13.4 | 4.8 | 1.86 | |||||
Gross Profit, 2 Yr. CAGR % | 38.54 | 36.94 | 21.76 | 11.85 | 4.87 | |||||
EBITDA, 2 Yr. CAGR % | 59.81 | 40.48 | 20.88 | 16.38 | 4.68 | |||||
EBITA, 2 Yr. CAGR % | 64.27 | 42.03 | 24.8 | 17.92 | 4.49 | |||||
EBIT, 2 Yr. CAGR % | 66.67 | 42.69 | 24.99 | 18.16 | 4.71 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 68.49 | 43.66 | 25.56 | 16.96 | 1.66 | |||||
Net Income, 2 Yr. CAGR % | 71.92 | 43.82 | 27.81 | 18.49 | 1.8 | |||||
Normalized Net Income, 2 Yr. CAGR % | 72.59 | 42.06 | 27.8 | 20.84 | 3.31 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 67.2 | 42.01 | 26.79 | 17.81 | 1.02 | |||||
Accounts Receivable, 2 Yr. CAGR % | 17.03 | 39.72 | 29.13 | 11.88 | 13.83 | |||||
Inventory, 2 Yr. CAGR % | 107.6 | 98.55 | 1.32 | 7.27 | -6.99 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 1.06 | 11.51 | 9.41 | 12.27 | 16.46 | |||||
Total Assets, 2 Yr. CAGR % | 14.88 | 31.89 | 11.94 | 10.69 | 5.12 | |||||
Tangible Book Value, 2 Yr. CAGR % | 3 | 12.39 | 12.27 | 12.46 | 7.18 | |||||
Common Equity, 2 Yr. CAGR % | 2.76 | 12.98 | 12.2 | 11.98 | 7.07 | |||||
Cash From Operations, 2 Yr. CAGR % | 25.7 | 47.43 | 28.2 | 16.31 | -18.59 | |||||
Capital Expenditures, 2 Yr. CAGR % | -27.08 | -8.4 | -30.79 | -29.72 | 20.48 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 482.27 | -60.4 | -6.3 | 404.86 | -36.27 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 523.5 | -58.35 | -5.86 | 428.04 | -35 | |||||
Dividend Per Share, 2 Yr. CAGR % | 99.5 | 80.26 | 7.5 | 24.9 | 3.92 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 25.84 | 26.43 | 24.29 | 8.1 | 5.08 | |||||
Gross Profit, 3 Yr. CAGR % | 30.08 | 38.9 | 28.46 | 17.94 | 7.53 | |||||
EBITDA, 3 Yr. CAGR % | 40.83 | 49.77 | 31.95 | 19.36 | 8.45 | |||||
EBITA, 3 Yr. CAGR % | 39.78 | 55.4 | 33.56 | 22.4 | 8.85 | |||||
EBIT, 3 Yr. CAGR % | 43.26 | 57.02 | 33.98 | 22.68 | 9.01 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 43.47 | 58.53 | 34.52 | 22.29 | 6.82 | |||||
Net Income, 3 Yr. CAGR % | 45.15 | 60.48 | 35.46 | 24.04 | 7.59 | |||||
Normalized Net Income, 3 Yr. CAGR % | 45.07 | 59 | 35.9 | 24.29 | 9.92 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 39.84 | 56.59 | 34.42 | 22.82 | 7.11 | |||||
Accounts Receivable, 3 Yr. CAGR % | 16.48 | 29.05 | 32.18 | 20.84 | 15.3 | |||||
Inventory, 3 Yr. CAGR % | 65.96 | 65.39 | 59.43 | 4.74 | -3.84 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 15.09 | 11.9 | 7.38 | 14.85 | 10.54 | |||||
Total Assets, 3 Yr. CAGR % | 17.73 | 18.77 | 24.01 | 11.88 | 6.6 | |||||
Tangible Book Value, 3 Yr. CAGR % | 15.65 | 9.05 | 11.84 | 12.9 | 8.36 | |||||
Common Equity, 3 Yr. CAGR % | 15.04 | 9.35 | 12.07 | 12.71 | 8.12 | |||||
Cash From Operations, 3 Yr. CAGR % | 23.67 | 27.61 | 41.66 | 19.35 | -4.66 | |||||
Capital Expenditures, 3 Yr. CAGR % | -8.81 | 6.73 | -30.8 | -15.71 | -16.93 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 161.64 | 13.34 | 31.44 | 24.39 | 61.96 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 161.3 | 22.4 | 32.17 | 24.65 | 69.33 | |||||
Dividend Per Share, 3 Yr. CAGR % | 107.65 | 64.14 | 50.07 | 20.12 | 3.95 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 19.3 | 24.32 | 22.45 | 17.29 | 14.78 | |||||
Gross Profit, 5 Yr. CAGR % | 20.68 | 27.41 | 28.28 | 27.38 | 18.45 | |||||
EBITDA, 5 Yr. CAGR % | 37.79 | 38.72 | 33.72 | 35.39 | 20.28 | |||||
EBITA, 5 Yr. CAGR % | 37.88 | 40.43 | 35.01 | 39.16 | 21.07 | |||||
EBIT, 5 Yr. CAGR % | 39.38 | 42.24 | 37.09 | 40.14 | 21.4 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 32.63 | 39.21 | 37.35 | 40.37 | 20.26 | |||||
Net Income, 5 Yr. CAGR % | 33.01 | 40.21 | 38.74 | 42.15 | 20.84 | |||||
Normalized Net Income, 5 Yr. CAGR % | 36.1 | 42.78 | 38.65 | 42.5 | 21.82 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 28.26 | 36.34 | 35.24 | 39.74 | 19.9 | |||||
Accounts Receivable, 5 Yr. CAGR % | 9 | 19.42 | 24.01 | 21.89 | 24.51 | |||||
Inventory, 5 Yr. CAGR % | 28.91 | 32.69 | 37.6 | 39.09 | 28.52 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 16.54 | 15.28 | 15.8 | 12.05 | 10.92 | |||||
Total Assets, 5 Yr. CAGR % | 17.15 | 21.17 | 17.83 | 15.47 | 16.08 | |||||
Tangible Book Value, 5 Yr. CAGR % | 14.13 | 17.21 | 15.94 | 10.4 | 9.95 | |||||
Common Equity, 5 Yr. CAGR % | 13.22 | 16.8 | 15.76 | 10.39 | 10.04 | |||||
Cash From Operations, 5 Yr. CAGR % | 39.86 | 18.46 | 26.62 | 22.97 | 13.5 | |||||
Capital Expenditures, 5 Yr. CAGR % | -7.05 | 5.27 | -7.29 | -9.7 | -13.62 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 40.58 | 11.51 | 61.94 | 115.25 | -3.67 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 40.79 | 12.95 | 62.12 | 121.51 | -2.56 | |||||
Dividend Per Share, 5 Yr. CAGR % | 64.84 | 67.02 | 59.57 | 47.15 | 29.55 |
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















